NeuroBo Pharmaceuticals Inc. (NRBO): Price and Financial Metrics


NeuroBo Pharmaceuticals Inc. (NRBO): $0.79

-0.02 (-2.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NRBO to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

NRBO Stock Price Chart Interactive Chart >

Price chart for NRBO

NRBO Price/Volume Stats

Current price $0.79 52-week high $63.85
Prev. close $0.81 52-week low $0.55
Day low $0.77 Volume 596,298
Day high $0.81 Avg. volume 1,592,188
50-day MA $1.11 Dividend yield N/A
200-day MA $10.43 Market Cap 5.14M

NeuroBo Pharmaceuticals Inc. (NRBO) Company Bio


NeuroBo Pharmaceuticals Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals conducts business in the United States.


NRBO Latest News Stream


Event/Time News Detail
Loading, please wait...

NRBO Latest Social Stream


Loading social stream, please wait...

View Full NRBO Social Stream

Latest NRBO News From Around the Web

Below are the latest news stories about NEUROBO PHARMACEUTICALS INC that investors may wish to consider to help them evaluate NRBO as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

The trading week is almost complete but we've still got the biggest pre-market stock movers to go over for Friday morning!

William White on InvestorPlace | December 9, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Thursday!

William White on InvestorPlace | November 10, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

William White on InvestorPlace | November 9, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

William White on InvestorPlace | November 8, 2022

NEUROBO ANNOUNCES CLOSING OF $32.3 MILLION UNDERWRITTEN PUBLIC OFFERING INCLUDING FULL EXERCISE OF OVERALLOTMENT OPTION AND CONCURRENT PRIVATE PLACEMENT

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) ("NeuroBo" or the "Company"), a clinical-stage biotechnology company focused on therapies for cardiometabolic diseases, today announced the closing of an underwritten public offering of units with gross proceeds of approximately $17.3 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional shares and warrants, prior to deducting underwriting discounts and commissions and offering expenses payable by

Yahoo | November 8, 2022

Read More 'NRBO' Stories Here

NRBO Price Returns

1-mo 10.10%
3-mo -88.71%
6-mo -92.96%
1-year -97.47%
3-year -99.71%
5-year -99.99%
YTD 10.10%
2022 -98.04%
2021 -76.76%
2020 -40.00%
2019 -56.79%
2018 -89.80%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6451 seconds.